BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34253484)

  • 21. Type 1 diabetes management: Room for improvement.
    Varkevisser RDM; Birnie E; Mul D; van Dijk PR; Aanstoot HJ; Wolffenbuttel BHR; van der Klauw MM
    J Diabetes; 2023 Mar; 15(3):255-263. PubMed ID: 36808864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social Risk Adjustment of Quality Measures for Diabetes and Cardiovascular Disease in a Commercially Insured US Population.
    Nguyen CA; Gilstrap LG; Chernew ME; McWilliams JM; Landon BE; Landrum MB
    JAMA Netw Open; 2019 Mar; 2(3):e190838. PubMed ID: 30924891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
    Shi X; He J; Lin M; Liu C; Yan B; Song H; Wang C; Xiao F; Huang P; Wang L; Li Z; Huang Y; Zhang M; Chen CS; Obst K; Li W; Yang S; Yao G; Li X
    Am Heart J; 2021 Aug; 238():45-58. PubMed ID: 33957103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social and behavioural risk factors in the prevention and management of cardiovascular disease in Kerala, India: a catchment area population survey.
    Madavanakadu Devassy S; Webber M; Scaria L; Amuthavalli Thiyagarajan J; Fendt-Newlin M; Joubert J; Benny AM; Nannatt A; Joubert L
    BMC Cardiovasc Disord; 2020 Jul; 20(1):327. PubMed ID: 32641078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data.
    Gordon-Dseagu VL; Mindell JS; Steptoe A; Moody A; Wardle J; Demakakos P; Shelton NJ
    PLoS One; 2015; 10(3):e0119882. PubMed ID: 25785731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
    Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
    Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality.
    Li FR; Yang HL; Zhou R; Zheng JZ; Chen GC; Zou MC; Wu XX; Wu XB
    Diabetes Obes Metab; 2021 Jun; 23(6):1361-1370. PubMed ID: 33620747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care.
    Baharudin N; Ramli AS; Ramland SS; Badlie-Hisham NI; Mohamed-Yassin MS
    J Prim Care Community Health; 2023; 14():21501319231191017. PubMed ID: 37551146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and Implementation of the Puerto Rico Observational Study of Psychosocial, Environmental, and Chronic Disease Trends (PROSPECT).
    Mattei J; Tucker KL; Falcón LM; Ríos-Bedoya CF; Kaplan RM; O'Neill HJ; Tamez M; Mendoza S; Díaz-Álvarez CB; Orozco JE; Acosta Pérez E; Rodríguez-Orengo JF
    Am J Epidemiol; 2021 May; 190(5):707-717. PubMed ID: 33083832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    Shah VN; Bailey R; Wu M; Foster NC; Pop-Busui R; Katz M; Crandall J; Bacha F; Nadeau K; Libman I; Hiers P; Mizokami-Stout K; DiMeglio LA; Sherr J; Pratley R; Agarwal S; Snell-Bergeon J; Cengiz E; Polsky S; Mehta SN
    J Clin Endocrinol Metab; 2020 May; 105(5):e2032-8. PubMed ID: 31955209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
    Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor glycemic control, cardiovascular disease risk factors and their clustering among patients with type 2 diabetes mellitus: A cross-sectional study from Nepal.
    Khanal MK; Bhandari P; Dhungana RR; Gurung Y; Rawal LB; Pandey G; Bhandari M; Devkota S; Courten M; Courten B
    PLoS One; 2022; 17(7):e0271888. PubMed ID: 35877664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
    Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
    Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis.
    McGurnaghan S; Blackbourn LAK; Mocevic E; Haagen Panton U; McCrimmon RJ; Sattar N; Wild S; Colhoun HM
    Diabet Med; 2019 Jun; 36(6):718-725. PubMed ID: 30246473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.
    Welsh C; Welsh P; Celis-Morales CA; Mark PB; Mackay D; Ghouri N; Ho FK; Ferguson LD; Brown R; Lewsey J; Cleland JG; Gray SR; Lyall DM; Anderson JJ; Jhund PS; Pell JP; McGuire DK; Gill JMR; Sattar N
    Diabetes Care; 2020 Feb; 43(2):440-445. PubMed ID: 31852727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A
    Lu J; He J; Li M; Tang X; Hu R; Shi L; Su Q; Peng K; Xu M; Xu Y; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Du R; Cheng D; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Chen L; Zhao J; Mu Y; Ning G; Wang W; Bi Y;
    Diabetes Care; 2019 Aug; 42(8):1539-1548. PubMed ID: 31152120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database.
    Yokote K; Suzuki R; Gouda M; Iijima H; Yamazaki A; Inagaki M
    J Diabetes Investig; 2021 Nov; 12(11):2036-2045. PubMed ID: 33988907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.